These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 39275928)
1. Evaluation of Anti-Hyperlipidemic Activity of the Seeds Extracts of Ficus carica: In Vitro and In Silico Approaches. Fayyaz S; Islam M; Ahmed A; Saeed H Cell Biochem Funct; 2024 Sep; 42(7):e4124. PubMed ID: 39275928 [TBL] [Abstract][Full Text] [Related]
2. Phytochemical, anti-hyperlipidemic and in silico studies of extracts of Ficus carica seeds. Fayyaz S; Islam M; Ahmed A; Saeed H; Naseem A Pak J Pharm Sci; 2023 May; 36(3(Special)):989-1000. PubMed ID: 37587709 [TBL] [Abstract][Full Text] [Related]
3. Bioassay-guided isolation and Saleem B; Islam M; Ahmed A; Saeed H; Imtiaz F; Muzaffar S J Biomol Struct Dyn; 2024 Sep; 42(15):8009-8023. PubMed ID: 37548653 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Efficiency of Ramadan S; Hegab AM; Al-Awthan YS; Al-Duais MA; Tayel AA; Al-Saman MA J Diabetes Res; 2021; 2021():6018835. PubMed ID: 34970629 [TBL] [Abstract][Full Text] [Related]
5. Molecular docking and dynamics simulation study of bioactive compounds from Ficus carica L. with important anticancer drug targets. Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM PLoS One; 2021; 16(7):e0254035. PubMed ID: 34260631 [TBL] [Abstract][Full Text] [Related]
6. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait. Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722 [TBL] [Abstract][Full Text] [Related]
7. Seeds, Leaves and Roots of Nebeg H; Benarous K; Serseg T; Lazreg A; Hassani H; Yousfi M Endocr Metab Immune Disord Drug Targets; 2019; 19(5):683-696. PubMed ID: 30706829 [TBL] [Abstract][Full Text] [Related]
8. Potential Effect of Baobab's Polyphenols as Antihyperlipidemic Agents: In Silico Study. Alameen AA; Alothman MR; Al Wahibi MS; Abdullah EM; Ali R; Abdalla M; Fattiny SZA; Elsayim R Molecules; 2023 Aug; 28(16):. PubMed ID: 37630364 [No Abstract] [Full Text] [Related]
9. The inhibitory potential of chemical constituents of Ficus carica targeting interleukin-6 (IL-6) mediated inflammation. Mansoor HUH; Ahmed A; Rasool F Cell Biochem Funct; 2023 Jul; 41(5):573-589. PubMed ID: 37222443 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats. Stephen Irudayaraj S; Christudas S; Antony S; Duraipandiyan V; Naif Abdullah AD; Ignacimuthu S Pharm Biol; 2017 Dec; 55(1):1074-1081. PubMed ID: 28193094 [TBL] [Abstract][Full Text] [Related]
11. Anti-obesity, antioxidant and in silico evaluation of Justicia carnea bioactive compounds as potential inhibitors of an enzyme linked with obesity: Insights from kinetics, semi-empirical quantum mechanics and molecular docking analysis. Anigboro AA; Avwioroko OJ; Akeghware O; Tonukari NJ Biophys Chem; 2021 Jul; 274():106607. PubMed ID: 33957576 [TBL] [Abstract][Full Text] [Related]
12. Changes in the phenolic and lipophilic composition, in the enzyme inhibition and antiproliferative activity of Ficus carica L. cultivar Dottato fruits during maturation. Marrelli M; Menichini F; Statti GA; Bonesi M; Duez P; Menichini F; Conforti F Food Chem Toxicol; 2012 Mar; 50(3-4):726-33. PubMed ID: 22222929 [TBL] [Abstract][Full Text] [Related]
13. The effects of Ficus carica on the activity of enzymes related to metabolic syndrome. Mopuri R; Ganjayi M; Meriga B; Koorbanally NA; Islam MS J Food Drug Anal; 2018 Jan; 26(1):201-210. PubMed ID: 29389556 [TBL] [Abstract][Full Text] [Related]
14. Fatty acids characterisation by GC-MS, antiglycation effect at multiple stages and protection of erythrocytes cells from oxidative damage induced by glycation of albumin of Opuntia ficus-indica (L.) Mill seed oil cultivated in Eastern Morocco: Experimental and computational approaches. Abdnim R; Lafdil FZ; Elrherabi A; El Fadili M; Kandsi F; Benayad O; Legssyer A; Ziyyat A; Mekhfi H; Bnouham M J Ethnopharmacol; 2024 Jul; 329():118106. PubMed ID: 38570146 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of pancreatic lipase by coffee leaves-derived polyphenols: A mechanistic study. Cao Q; Mei S; Mehmood A; Sun Y; Chen X Food Chem; 2024 Jun; 444():138514. PubMed ID: 38310782 [TBL] [Abstract][Full Text] [Related]
17. In silico and in vitro analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat. Mandal SK; Kumar BK; Sharma PK; Murugesan S; Deepa PR Comput Biol Med; 2022 Aug; 147():105796. PubMed ID: 35809408 [TBL] [Abstract][Full Text] [Related]
18. Lepidine B & E as New Target Inhibitors from Lepidium Sativum Seeds Against Four Enzymes of the Pathogen Candida albicans: In Vitro and In Silico Studies. Gacemi S; Benarous K; Imperial S; Yousfi M Endocr Metab Immune Disord Drug Targets; 2020; 20(1):127-138. PubMed ID: 30987578 [TBL] [Abstract][Full Text] [Related]
19. Lipase activity inhibited by aloenin A: Glycoside from Aloe vera (L.) Burm. f.-In vitro and molecular docking studies. Deora N; Venkatraman K J Mol Recognit; 2023 Feb; 36(2):e3002. PubMed ID: 36495231 [TBL] [Abstract][Full Text] [Related]
20. Antidiabetic Activity, Molecular Docking, and ADMET Properties of Compounds Isolated from Bioactive Ethyl Acetate Fraction of Olaokun OO; Zubair MS Molecules; 2023 Nov; 28(23):. PubMed ID: 38067448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]